WAUKESHA WI. - GE Medical Systems has signed a clinical trial agreement with the Cancer Imaging Program of the National Cancer Institute (NCI) for multi-site clinical trials of 18F-Fluorothymidine (FLT) as an agent for positron emission tomography (PET) applied to the managemen